View source for CR:DOI:70a074020eb2011fea1bcf61c6576f78

{{#scite:
 |reference=nyang’wa2022a 
 |type=journal-article
 |title=A 24-Week, All-Oral Regimen for Rifampin-Resistant Tuberculosis
 |author=Bern-Thomas Nyang’wa;Catherine Berry;Emil Kazounis;Ilaria Motta;Nargiza Parpieva;Zinaida Tigay;Varvara Solodovnikova;Irina Liverko;Ronelle Moodliar;Matthew Dodd;Nosipho Ngubane;Mohammed Rassool;Timothy D. McHugh;Melvin Spigelman;David A.J. Moore;Koert Ritmeijer;Philipp du Cros;Katherine Fielding|+sep=;
 |journal=New England Journal of Medicine
 |publisher=Massachusetts Medical Society
 |year=2022
 |volume=387
 |issue=25
 |pages=2331-2343
 |doi=10.1056/nejmoa2117166
 |issn=0028-4793;1533-4406|+sep=;
 |retrieved-from=https://dx.doi.org/
 |retrieved-on=2024-09-19
 |@show=true
}}